SARS-CoV-2 Nucleocapsid proteins for LFT Revalidation and Testing
Estimated value
£500k
Awarded value
£500k
Awarded 26 Jan 2023
Suppliers
1
Lots
1
1 awarded
Published
27 Jan 2023
Deadline 25 Jan 2023
Description
Provision of SARS-CoV-2 Nucleocapsid proteins for LFT Revalidation and Testing.
Scope
- Reference
- CF-1300200D0O000000rwimUAA
- Total value
- £500,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 26 Jan 2023 to 30 Mar 2023
- CPV classifications
- 33651520
Submission & procedure
- Submission deadline
- 25 Jan 2023, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£500k
Award date
26 Jan 2023
Contract start
26 Jan 2023
Contract end
30 Mar 2023
Awarded to